Bloomington, IL- GenInvo provides a unique combination of expertise in life sciences, leading-edge technologies and software development, enabling us to provide truly innovative and transformative products, solutions and services. During the pandemic of the Covid-19 virus, GenInvo strives to support our clients who develop, screen, and test drugs to find a treatment for this disease as fast as possible. We are proud to be a part of the solution.

At GenInvo, we see the Impact of Innovation up close daily, from our client’s perspective. We strive to develop efficient, innovative products and solutions for our clients to make the drug development process smarter, faster, and more cost effective. Innovation is an essential element of the corporate mission and success of these clients. GenInvo supports their journey, working collaboratively to understand the needs of their systems, processes and their current challenges within these areas.

Geninvo has a strong pipeline of Innovative products built using advanced technologies to support the unmet gaps and have launched state-of-the-art products such as Shadow and DocQC. We continue to build new, robust, innovative products. ApoGI, is an example of an integrated automation platform that leverages AI (artificial intelligence) and ML (machine learning) to focus on standards in metadata management to streamline processes, and the generation of artefacts typically associated with the clinical study lifecycle.

As the Director of Innovation Solutions and Strategy, Ramesh Venkataramana comments “With many years of experience in various Pharma Organizations, there are gaps within the current landscape of Process/Systems/Tools usage within the respective organizations current legacy Drug Development portfolio. From Study setup to Study Closure, Pharma Companies have started to look for futuristic, long term, efficient solutions which are streamlined, automated, and will deliver on time with quality on an advanced platform within a regulated environment. Geninvo has the like-minded group of talented people who understand from the Client’s perspective and develop Innovative Solutions to address these gaps sooner.”

Geninvo understands the demand for people with knowledge and skills in artificial intelligence and machine learning hugely exceeds the supply. We continue searching for talented, experienced professionals to join our innovative, solution providing, life changing organization.

At this critical time as COVID-19 is spreading around the globe, we at Geninvo consider the safety of all our employees very important and have advised them to work from home to keep everyone safe and healthy. Regardless of the situation, the product development timeline is still on track. This shows the dedication of our employees and their commitment to the life science industry, while allowing employees to balance their work and personal time spent with their family. Geninvo has been supporting communities around the Bloomington-Normal area. Recently providing 100’s of lunches to a nearby school during this difficult time and are ready to support many more in the future.

Over the next few months, Geninvo will continue to invest in the advanced technology areas to build strong products for the life sciences domain while scaling to other industries. Email us with questions at

Skip to content